Clinical trial
Clinical Evaluation of the Safety and Performance of Fractional Radiofrequency for the Treatment and Reduction of Acne Scarring
NCT04827680 is registered in ClinicalTrials.gov with Venus Concept as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Safety and Performance of Fractional Radiofrequency for the Treatment and Reduction of Acne Scarring
- Lead sponsor
- Venus Concept
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2021
- Completion date
- June 13, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acne scars - mixed atrophic and hypertrophic